COVID-19: Vaccines and Therapeutics

The Department of Health and Human Services’ Office of the Assistant Secretary for Preparedness and Response and Food and Drug Administration this week extended the shelf life for certain refrigerated lots of the COVID-19 combination monoclonal antibody therapies REGEN-COV and Evusheld.
Seattle Children’s Hospital is taking a collaborative approach with parents to vaccinate very young children against COVID-19
The Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices today unanimously recommended Moderna’s COVID-19 vaccine for children aged 6-11 and adolescents aged 12-17. The FDA last week authorized the vaccine for these ages. If the CDC endorses ACIP’s…
The CDC's Advisory Committee on Immunization Practices on Saturday recommended the Moderna vaccine and the Pfizervaccine for children of certain ages.
The Food and Drug Administration today authorized Moderna’s COVID-19 vaccine for children aged 6 months through 17 years old and Pfizer’s COVID-19 vaccine for children aged 6 months through 4 years old, as recommended this week by its vaccine advisory committee.
A Food and Drug Administration advisory committee today recommended the agency authorize Moderna’s COVID-19 two-dose vaccine for children aged 6 months through 5 years old and Pfizer’s three-dose COVID-19 vaccine for children aged 6 months through 4 years old
An initial 10 million doses of COVID-19 vaccine are available for children under age 5 if the Food and Drug Administration authorizes and the Centers for Disease Control and Prevention recommends the Pfizer and Moderna vaccines for children in this age group, Assistant Secretary for Preparedness…
The AHA today published two new posters highlighting the long history of vaccines
The Food and Drug Administration Friday released an updated checklist to help clinicians screen patients for potential drug interactions before prescribing the Pfizer antiviral pill Paxlovid.